Suchergebnisse - "Shah, Devron R"

PubPharm (23)

1

Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology

enthalten in: Drug safety | 2019

von Shah, R. | Shah, D.

2

Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology

enthalten in: Medical toxicology | 2019

von Shah, R. | Shah, D.

3

Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology

enthalten in: Drug safety | 2019

von Shah, R. | Shah, D.

4

Effect of tyrosine kinase inhibitors on wound healing and tissue repair : implications for surgery in cancer patients

enthalten in: Drug safety | 2014

von Shah, D. | Dholakia, S. | Shah, R.

5

Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients

enthalten in: Medical toxicology | 2014

von Shah, D. | Dholakia, S. | Shah, R.

6

Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients

enthalten in: Drug safety | 2014

von Shah, D. | Dholakia, S. | Shah, R.

7

Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients

enthalten in: Drug safety | 2014

von Shah, D. | Dholakia, S. | Shah, R.

8

A fresh perspective on comparing the FDA and the CHMP/EMA : approval of antineoplastic tyrosine kinase inhibitors

enthalten in: British journal of clinical pharmacology | 2013

von Shah, R. | Roberts, S. | Shah, D.

9

Hepatotoxicity of tyrosine kinase inhibitors : clinical and regulatory perspectives

enthalten in: Drug safety | 2013

von Shah, R. | Morganroth, J. | Shah, D.

10

Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives

enthalten in: Medical toxicology | 2013

von Shah, R. | Morganroth, J. | Shah, D.